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Dominant spinal muscular atrophy is
caused by mutations in BICD2, an
important golgin protein
Lilian A. Martinez-Carrera and Brunhilde Wirth *
Institute of Human Genetics, Institute for Genetics and Center for Molecular Medicine of The University of Cologne, Cologne,
Germany
Spinal muscular atrophies (SMAs) are characterized by degeneration of spinal motor
neurons and muscle weakness. Autosomal recessive SMA is the most common form
and is caused by homozygous deletions/mutations of the SMN1 gene. However, families
with dominant inherited SMA have been reported, for most of them the causal gene
remains unknown. Recently, we and others have identified heterozygous mutations
in BICD2 as causative for autosomal dominant SMA, lower extremity-predominant, 2
(SMALED2) and hereditary spastic paraplegia (HSP). BICD2 encodes the Bicaudal D2
protein, which is considered to be a golgin, due to its coiled-coil (CC) structure and
interaction with the small GTPase RAB6A located at the Golgi apparatus. Golgins are
resident proteins in the Golgi apparatus and form a matrix that helps to maintain the
structure of this organelle. Golgins are also involved in the regulation of vesicle transport.
In vitro overexpression experiments and studies of fibroblast cell lines derived from
patients, showed fragmentation of the Golgi apparatus. In the current review, we will
discuss possible causes for this disruption, and the consequences at cellular level, with
a view to better understand the pathomechanism of this disease.
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Spinal muscular atrophy (SMA) is a diverse group of genetic disorders characterized by aberrant
development and/or loss of spinal motor neurons, and muscle weakness without sensory neuron
involvement (Wee et al., 2010). SMA is usually classified by the pattern of weakness (i.e., proximal
or distal) and mode of inheritance (autosomal recessive, autosomal dominant, X-linked).
Autosomal recessive SMA linked to chromosome 5 (5q-SMA) is the most common form
accounting for up to 95% of the SMA cases, and is caused by homozygous deletion/mutation of
the survival motor neuron 1 (SMN1) gene, localized on chromosome 5q12-q13 (Lefebvre et al.,
1995; Wirth, 2000). The 5q-SMA is classified into different types based on onset and severity of
symptoms. The most severe form of 5q-SMA (type I) has an onset within the first 6 months of life,
permanent inability to seat without support and usually death within 2 years (Iannaccone et al.,
1993; Rudnik-Schöneborn et al., 1996). The intermediate form of 5q-SMA (type II) has an onset
between 6 and 18 months of life, ability to seat but not to walk and death usually occurs after the
age of 2 years. A milder form is the 5q-SMA type III with an onset at around 3 years of age, ability
to stand and walk but because of progressive muscle weakness, the patients mostly are wheelchair-
bound as the disease progresses (Zerres and Rudnik-Schöneborn, 1995; Zerres et al., 1995). The
5q-SMA type IV, also called “adult SMA,” is considered the mildest and less severe form with a late
onset of around 30 years of age (Zerres et al., 1995). All the mentioned forms of 5q-SMA commonly
share proximal muscle weakness with slow progression in case of type II-IV SMA.
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In contrast to autosomal recessive 5q-SMA, the autosomal
dominant SMA (ADSMA) forms are less frequent, milder,
with vague progression and probably, even under-diagnosed. In
approx. 70% of individuals with ADSMA the genetic cause is
still unknown. However, due to remarkable advances in next
generation sequencing and gene discovery, the number of newly
described causative genes increases continuously.
Beside autosomal dominant SMA lower extremity-
predominant 1 (SMALED1, OMIM #58600) caused by
mutations in dynein cytoplasmic 1 heavy chain 1 protein
(DYNC1H1; OMIM ∗600112), we and others have recently
identified heterozygous variants in BICD2 (OMIM ∗609797)
as causative for autosomal dominant SMA, lower extremity-
predominant, 2, (SMALED2; OMIM #615520) and hereditary
spastic paraplegia (HSP) (Neveling et al., 2013; Oates et al., 2013;
Peeters et al., 2013).
CLINICAL FEATURES OF INDIVIDUALS
CARRYING MUTATIONS IN BICD2
Individuals carrying heterozygous missense variants in BICD2
exhibit muscle weakness and atrophy predominantly of the
proximal lower limbs. However, in some cases the distal
lower limbs are also affected, and in few others upper
limbs are additionally compromised. The initial reasons for
clinical counseling are commonly the difficulties in walking
(waddling gait and toe walking), and delayed motor milestones.
Contractures are reported frequently, and few patients present
congenital hip dysplasia. Notoriously, many patients show
evident wasting of the lower limbs and a very broad upper body,
which resembles a bodybuilder-like shape. Symptoms are usually
present at birth or appear in early childhood, but some cases
with adult onset have been also described (Table 1; Neveling
et al., 2013; Oates et al., 2013; Peeters et al., 2013; Synofzik
et al., 2014; Rossor et al., 2015). The course of disease is slowly
progressive or non-progressive. Due to the mild phenotype,
patients are sometimes diagnosed as SMA type IV, the mildest
form of the classical 5q-SMA. However, most cases of SMALED2
present a congenital or early onset with foot deformities and joint
contractures, and difficulties when began walking (Frijns et al.,
1994; Adams et al., 1998; Oates et al., 2012; Neveling et al., 2013).
One infant who died of other causes at 14 months of age showed
in the post-mortem examination decreased number of anterior
horn cells in the lumber and cervical spine with no peripheral
nerve pathology confirming a SMA (Oates et al., 2012).
Two families affected by an HSP phenotype associated to
BICD2 variants, have been described (Oates et al., 2013; Novarino
et al., 2014). In the first family, the affected individuals presented
features in adulthood, and showed lower-limb spasticity and
hyperreflexia as is typical for HSP. It is also reported, a slow
progression of contractures, weakness, and wasting (Oates et al.,
2013). Regarding the association of this specific variant with
the development of HSP but not SMALED2, it would be of
particular interest to exclude the involvement of secondary
disease-causing genes, resulting then in a multigenic disease,
instead of a monogenic form. The second family with HPS
linked to BICD2 is consanguineous, and the affected individuals
carry the homozygous variant in BICD2, c.G1823A, p.S608L
(Novarino et al., 2014). This variant was identified by whole-
exome sequencing in combination with network analysis, and is
the only homozygous variant reported in BICD2 so far.
Numerous experimental attempts have been made leading to
a better understanding of the physiological role of BICD2 and
yielded first insights into possible effects of variants in BICD2
on a cellular and molecular level (Table 2). However, further
investigation is needed to fully understand the pathomechanism
of how mutations in BICD2 can cause SMALED2 and rarely
HSP-like phenotype. Next, we summarize the mutation spectrum
and functional knowledge about BICD2, and focus on Golgi
fragmentation as a cellular consequence of certain BICD2
mutations, as a possible mechanism to explain failure in neuronal
development and maintenance.
GENETIC SPECTRUM OF PATHOGENIC
VARIANTS FOUND IN BICD2 IN PATIENTS
WITH SMALED2
BICD2 localizes in chromosomal region 9q22.31 and encodes a
canonical isoform of 824 amino acids. All the variants found
in patients with SMALED2 are heterozygous and lead to single
amino acid substitutions (Figure 1). The most common variant
reported is the c.320C>T, p.Ser107Leu, found in 29 of 49 cases
corresponding to 5 of 13 families described with SMALED2. This
variant is located within a CpG dinucleotide (Neveling et al.,
2013; Oates et al., 2013; Peeters et al., 2013; Bansagi et al., 2015;
Rossor et al., 2015). The cytosine-guanine (CpG) dinucleotide
is considered a hotspot for pathological variants. Cytosine is
subject for methylation however, spontaneous deamination of 5-
methylcytosine may occur, yielding thymine instead (Shen et al.,
1994).
BICD2 IS HIGHLY CONSERVED AMONG
SPECIES
Bicaudal-D (BicD) was identified first in Drosophila melanogaster
in a mutant screen for dominant maternal-effect proteins. Loss-
of-function mutations in BicD interfere with the determination
of the oocyte, while gain-of-function substitutions (e.g.,
p.Glu224Lys, p.Phe684Ile) disrupt the establishment of anterior
and posterior polarity giving rise to bicaudal (two tails) embryos
(Mohler and Wieschaus, 1986; Steward, 1987; Schüpbach and
Wieschaus, 1991). BicD null mutations are recessively lethal (Ran
et al., 1994). Further studies show that BicD is a component of
dynein-based transport and is implicated in the transport of
mRNA (e.g., clathrin heavy chain and osk) to specific cellular
regions of the fly during oogenesis and embryogenesis (Figure 2;
Bullock and Ish-Horowicz, 2001). Experimental evidence
suggested that BicD, together with clathrin heavy chain, mediates
endocytosis during oocyte development (Vazquez-Pianzola et al.,
2014). BicD is also involved in the regulation of bi-directional
transport of lipid droplets (Larsen et al., 2008).
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TABLE 2 | Summary of possible molecular mechanism involved in SMALED2 due to BICD2 substitutions.
Variant/Mutation Mechanism proposed Mechanism proposed by
c.320C>T/ p.Ser107Leu Higher interaction with DIC and p150Glued subunit of dynactin Oates et al., 2013; Peeters et al., 2013
c.563A>C/p.Asn188Thr Slight Golgi fragmentation Neveling et al., 2013
c.1502G>C/p.Arg501Pro Higher interaction with DIC and p150Glued subunit of dynactin Oates et al., 2013
c.2108C>T/p.Thr703Leu Prominent Golgi fragmentation Neveling et al., 2013
c.2321A>G/p.Glu774Gly Less interaction with Rab6a Peeters et al., 2013
FIGURE 1 | Schematic representation of BICD2. The diagram depicts the coiled-coil domains (CC) of BICD2 indicating the corresponding interacting partners. The
position of variants, found in patients with SMALED2 is shown (Neveling et al., 2013; Oates et al., 2013; Peeters et al., 2013; Synofzik et al., 2014; Rossor et al., 2015).
There is only one BicD gene in invertebrates, while mammals
have two homologs BICD1 and BICD2. BICD1 and BICD2
interact with the dynein-dynactin motor complex (Hoogenraad
et al., 2001), and both have been associated with Golgi-ER
transport (Matanis et al., 2002). Studies in Bicd2 knockout mice
revealed, that BICD2 has an important role in neuronal cell
migration (Figure 2) (Jaarsma et al., 2014). The Bicd2 knockout
mice present severe developmental defects of the cerebellar
cortex, however other brain regions and spinal cord appear
normal (Jaarsma et al., 2014).
BICD2 STRUCTURE AND ORGANIZATION
Studies in Drosophila revealed that more than half of the BicD
protein consists of heptad repeats. A heptad repeat is a repeating
pattern of seven amino acids where hydrophobic residues are
preferentially located at positions 1 and 4 (McLachlan and Karn,
1983). These heptad repeats mediate the packaging of one helix
against another, forming coiled-coil (CC) structures made up
of two or three protein molecules and resulting in homo- or
heterodimers or in multimers (Bruccoleri et al., 1986). The
BICD protein is predicted to consist of CC domains: the N-
terminal domain contains the coiled-coil segment 1 (CC1) and
the coiled-coil segment 2 (CC2), and the C-terminal contains the
coiled-coil segment 3 (CC3). Studies inDrosophila and mammals
suggested, that BICD interacts with itself forming homodimers
(Oh et al., 2000; Hoogenraad et al., 2001). In the case of BICD2,
the segment 1 of the N-terminal domain (CC1, amino acids 10–
321) binds to the C-terminal segment (CC3, amino acids 706–
810) (Hoogenraad et al., 2001). A hypothetical model proposes
that as a result of this interaction between segments, the soluble
free BICD2 folds up, and only when C-terminal segment engages
in an interaction with other proteins, the N-terminal segment of
the BICD2 becomes available for interaction with other proteins
(Hoogenraad et al., 2001). These protein interactions seem to
be determining for the cellular distribution of BICD2 and the
fulfillment of its specific function (Figures 1, 2).
THE ROLE OF BICD2 IN THE GOLGI
APPARATUS AND DYNEIN-DYNACTIN
COMPLEX
One of the most studied binding partners of BICD2 is the
dynein-dynactin complex. Cytoplasmic dynein is the major
responsible motor protein for transporting a large variety of
cargos toward the minus ends of microtubules (Kardon and
Vale, 2009). Dynactin is a protein complex that stimulates dynein
processivity and participates in cargo binding (Holleran et al.,
Frontiers in Neuroscience | www.frontiersin.org 4 November 2015 | Volume 9 | Article 401
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FIGURE 2 | Functions of BICD2 in the cell. Cellular process with BICD2 involvement as described from studies in mammals or Drosophila are shown. BICD2 binds
to RAB6A and recruits the dynein-dynactin complex to the trans-Golgi to facilitate COPI-independent Golgi-ER transport (Hoogenraad et al., 2001, 2003; Matanis
et al., 2002). Prior mitosis (during G2 phase), BICD2 binds to a component of the nuclear pore complex, the RANBP2, and recruits dynein-dynactin to keep
centrosomes tethered to the nucleus (Splinter et al., 2012). Studies in D. melanogaster have shown that BicD participates in mRNA transport (Bullock and
Ish-Horowicz, 2001), endocytosis together with clathrin heavy chain (Vazquez-Pianzola et al., 2014), and in the regulation of bi-directional transport of lipid droplets
(Larsen et al., 2008).
1998; Schroer, 2004). Dynein and dynactin directly bind to each
other through the interaction of dynein intermediate chain and
dynactin subunit p150 (Vaughan et al., 1995; Waterman-Storer
et al., 1995; King et al., 2003). The N-terminal domain of BICD2
binds to the dynein-dynactin complex via interaction with the
p50 subunit of the dynactin complex (Hoogenraad et al., 2001).
Studies in vivo and in vitro suggested, that the N-terminus
of BICD2 promotes a stable interaction between dynein and
dynactin (Splinter et al., 2012). In this context it is particularly
interesting to mention that mutations in cytoplasmic dynein
DYNC1H1 causes SMALED1 (Harms et al., 2012; Tsurusaki
et al., 2012; Peeters et al., 2015). See the Review Jaarsma and
Hoogenraad (2015).
The C-terminal segment of BICD2 shows the highest degree
of evolutionary conservation and is described as the cargo-
binding domain (Hoogenraad et al., 2001; Terenzio and Schiavo,
2010). BICD2 is considered a linker protein that acts between a
cargo bound to its C-terminal segment and the dynein-dynactin
complex associated to its N-terminal segment. The C-terminal
segment of BICD2 binds strongly to the active form of the RAB6A
GTPase and is responsible for Golgi targeting (Hoogenraad et al.,
2001, 2003).
RAB6A is part of a big RAB family of more than 60 members
(Zerial and McBride, 2001). RAB proteins shift dynamically
between an active membrane-associated GTP-bound form and
an inactive cytosolic GDP-bound form (Pfeffer, 2001; Zerial and
McBride, 2001). RAB proteins are associated with membranes via
geranylgeranyl groups that are attached to cysteine residues at
the C-terminus (Stenmark, 2009). Guanine nucleotide exchange
factors (GEFs) are responsible for the activation of RAB proteins
by catalyzing the exchange of GDP for GTP (Delprato et al.,
2004; Stenmark, 2009). Experimental evidence suggested that
GEFs are responsible for targeting the RAB proteins to specific
membranes (Gerondopoulos et al., 2012; Blümer et al., 2013).
The active, membrane-bound RAB proteins are involved in
membrane traffic, by binding with specific proteins (Grosshans
et al., 2006).
The small GTPase RAB6A is involved in intra-Golgi transport.
Several studies support that RAB6A coordinates the retrograde
COPI-independent Golgi-ER pathway, which is considered
a recycling route for Golgi-resident glycosylation enzymes
(Martinez et al., 1997; Girod et al., 1999;White et al., 1999; Storrie
et al., 2000). The active form of RAB6A (GTP-bound) recruits
BICD2 to the trans-Golgi membrane via direct interaction with
the C-terminal domain of BICD2 (Hoogenraad et al., 2001;
Matanis et al., 2002; Short et al., 2002; Bergbrede et al., 2009;
Matsuto et al., 2015). Recent reports suggest that BICD2 may
stabilize the active RAB6A, by inhibiting its GTPase activity and
thus increasing the GTP-bound membrane-associated RAB6A
(Matsuto et al., 2015). Once the C-terminal segment of
BICD2 binds to RAB6A, the N-terminal segment of BICD2
becomes available and recruits the dynein-dynactin complex.
This recruitment is considered a critical step for the microtubule
retrograde traffic. In this manner, a coordinated action between
RAB6A, BICD2 and the dynein-dynactin complex controls
COPI-independent Golgi-ER transport (Matanis et al., 2002).
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Hence BICD2 has an abundant CC structure, localizes at the
Golgi complex, and interacts with a member of the RAB family of
GTPases (RAB6A), it is considered to be a golgin (Barr and Short,
2003; Short et al., 2005; Goud and Gleeson, 2010).
Golgins are proteins associated with the Golgi apparatus
and help to maintain the organized architecture of this
dynamic organelle. One type of golgins consists of resident
transmembrane-Golgi proteins which are necessary for tethering
membranes together (Barr and Short, 2003). Another type of
golgins corresponds to proteins that are recruited to the Golgi
apparatus, and are associated with components of the trafficking
machinery. BICD2 is included in this last class (Barr and Short,
2003).
MUTATIONS IN BICD2 CAUSE GOLGI
FRAGMENTATION
The effects of the BICD2 domains on the integrity of the
Golgi apparatus have been studied in detail (Hoogenraad
et al., 2001, 2003; Splinter et al., 2012). Although the C-
terminal domain targets the BICD2 to the Golgi apparatus, the
overexpression of the N-terminal segment perturbs the Golgi
organization (Hoogenraad et al., 2001). Fragmentation of the
Golgi apparatus has been associated with inhibition of dynein
function (Burkhardt et al., 1997; Harada et al., 1998; Quintyne
et al., 1999).
Based on the association of BICD2 with RAB6A and Golgi
targeting, we performed immunofluorescent staining of the Golgi
apparatus of fibroblast cells derived from the patients carrying
heterozygous mutations in BICD2.
We observed a prominent fragmentation of the Golgi
apparatus in primary fibroblast cells harboring the p.Thr703Leu
substitution (C-terminal) and a milder fragmentation in cells
with the p.Asn188Thr substitution (N-terminal) (Neveling
et al., 2013) (Figure 3). The individuals carrying the mutation
p.Thr703Leu show amore severe phenotype including congenital
contractures, while the individuals carrying the mutation
p.Asn188Thr do not present contractures. Thus, in the case of
these two cell lines showing Golgi fragmentation, the grade of
fragmentation seems to correlate with the severity of the disease
(Neveling et al., 2013). Although, Golgi fragmentation is not a
common feature in all the cell lines carrying mutations in BICD2
(Oates et al., 2013; Peeters et al., 2013).
The BICD2 mutations p.Thr703Leu and p.Asn188Thr
may cause fragmentation of the Golgi apparatus due to
conformational changes of BICD2 that alter protein function and
affect the structure of the Golgi. How amino acid substitution
at the positions Thr703 and Asn188 impact intramolecular
interactions and probably protein folding remains elusive,
as there is no crystalloid structure of BICD2 or the region
harboring these mutations available. The alteration in the Golgi
structure could also be a secondary effect of alteration in the
microtubule organization. The integrity and positioning of the
FIGURE 3 | The mutations in BICD2, p.Thr703Leu and p.Asn188Thr, triggered Golgi-fragmentation in Primary Fibroblast Cells. (A–C) Modified data as
published previously (Neveling et al., 2013), showing the Golgi apparatus of control fibroblasts and patients fibroblasts. The Golgi apparatus was immunostained with
antibody against the Golgi marker ML160. (D–F) Magnification in monochrome of (A–C) for better visualization and comparison. Please note the prominent unfolded
and disperse structure of the Golgi apparatus in cells carrying the mutation p.Thr703Leu and the intermedium or mild dispersion in the cells carrying the mutations
p.Asn188Thr. For detail information and quantification, please read (Neveling et al., 2013).
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Golgi apparatus seems to have an important role in neuronal
polarization and development (de Anda et al., 2005).
POTENTIAL CONSEQUENCES OF GOLGI
FRAGMENTATION ON NEURONAL
DEVELOPMENT AND MAINTENANCE
Proper development of neurons is vital to fulfill and maintain the
precise connectivity of the nervous system. Neurons are among
themost polarized cell types and consist of a cell body fromwhich
specialized structures emerge, the neurites. In a very coordinated
process, only one of the neurites grows long becoming an axon,
while the other neurites acquire dendritic identity (Goslin et al.,
1989; Craig and Banker, 1994; Polleux and Snider, 2010).
Previous studies have shown that in completely
undifferentiated neurons, the centrosomes, Golgi apparatus
and late/recycling endosomes cluster together to the area where
the first neurite will form, which is in turn opposite from the
plane of the last mitotic division (de Anda et al., 2005). The
coordinated activity of these organelles is necessary for the
polarization of the neuron.
Besides axon development, it has been suggested that the
Golgi apparatus has an important role in dendrite maintenance
and shape (Horton and Ehlers, 2003; Lewis and Polleux, 2012;
Ori-McKenney et al., 2012). Non-neuronal cells contain one
Golgi apparatus while many neurons contain several Golgi, the
somatic Golgi and the dendritic Golgi centers called “Golgi
outposts.” These dendritic Golgi outposts function similarly to
the somatic Golgi, providing dendrites with substantial secretory
capacity. The Golgi outposts appear during early neuronal
differentiation, and may form as fragments derived from somatic
Golgi that expand into dendrites, as the dendrites grow (Horton
and Ehlers, 2003). The Golgi structure, dynamics and localization
seem to have an important effect on neuronal development and
maintenance, and an alteration in any of them could trigger
degeneration or failure in correct maturation.
Additionally to SMALED2, other motor neurodegenerative
diseases like ALS, have been associated with Golgi fragmentation
(Gonatas et al., 1992; Mourelatos et al., 1994). However, it
is still not clear why motor neurons but not other neuronal
cells are affected. This effect might be attributable, to specific
requirements of motor neurons during development that are
different from other neuronal populations.
In conclusion, pathogenic substitutions in BICD2 causes
SMALED2 with an autosomal dominant inheritance. Patients
with SMALED2 show slowly to non-progressivemuscle weakness
of proximal and distal mainly of lower extremities, with a quite
broad clinical spectrum. Themajority of patients show congenital
or early onset with foot deformities and joint contractures.
However, some patients present a late onset and have very
mild and non-progressive appearance. Commonly seems to be a
wide aperture of the upper body (body-building shape). BICD2
is a golgin adaptor protein. The various BICD2 substitutions
found in patients with SMALED2 impair interaction to other
binding partners such as dynein-dynactin, RAB6A etc. and thus
impair most likely cellular processes such as axonal transport,
vesicular transport, Golgi integrity etc, which however needs
further intensive functional studies. It is not understood why
these mutations cause specifically loss of spinal motor neurons,
since BICD2 is expressed in all neurons, is essential in neuronal
migration and in positioning of the nucleus in the cell. There is
also a quite broad phenotypic variability even in patients with
the samemutation, suggesting the influence of modifying factors,
which also need to be investigated.
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